These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 9280724)

  • 1. [Differences in pharmacologic treatment after acute myocardial infarction. The role of treatment effectiveness].
    Bobbio M; Imazio M; Tidu M; Presbitero P; Trinchero R; Brusca A
    G Ital Cardiol; 1997 Jun; 27(6):549-56. PubMed ID: 9280724
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacological treatment after acute myocardial infarction from 2001 to 2006: a survey in Italian primary care.
    Filippi A; D'Ambrosio G; Giustini SE; Pecchioli S; Mazzaglia G; Cricelli C
    J Cardiovasc Med (Hagerstown); 2009 Sep; 10(9):714-8. PubMed ID: 19465867
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Usefulness of beta blockers in high-risk patients after myocardial infarction in conjunction with captopril and/or valsartan (from the VALsartan In Acute Myocardial Infarction [VALIANT] trial).
    Califf RM; Lokhnygina Y; Velazquez EJ; McMurray JJ; Leimberger JD; Lewis EF; Diaz R; Murin J; Pfeffer MA
    Am J Cardiol; 2009 Jul; 104(2):151-7. PubMed ID: 19576338
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of combined beta-blocker and angiotensin-converting enzyme inhibitor treatment on 1-year survival after acute myocardial infarction: findings of the PRIAMHO-II registry].
    Arós F; Loma-Osorio A; Vila J; López-Bescós L; Cuñat J; Rodríguez E; San José JM; Heras M; Marrugat J;
    Rev Esp Cardiol; 2006 Apr; 59(4):313-20. PubMed ID: 16709383
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Drug prescription in myocardial postinfarction: results of the EPPI (étude de prescription postinfarctus). A French cooperative study].
    Boissel JP; Némoz C; Gillet J; Salewski B; Diaz N
    Arch Mal Coeur Vaiss; 1990 Nov; 83(12):1777-82. PubMed ID: 1980055
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prescription of cardiovascular drugs in outpatient care: a survey of outpatients in a German university hospital.
    Harder S; Thürmann P; Thierolf C; Klepzig H
    Int J Clin Pharmacol Ther; 1998 Apr; 36(4):195-201. PubMed ID: 9587045
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Do the results of randomized clinical trials of cardiovascular drugs influence medical practice? The SAVE Investigators.
    Lamas GA; Pfeffer MA; Hamm P; Wertheimer J; Rouleau JL; Braunwald E
    N Engl J Med; 1992 Jul; 327(4):241-7. PubMed ID: 1535419
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Aldosterone receptor antagonist use after myocardial infarction. Data from the REICIAM registry].
    López-de-Sá E; Martínez A; Anguita M; Dobarro D; Jiménez-Navarro M;
    Rev Esp Cardiol; 2011 Nov; 64(11):981-7. PubMed ID: 21924809
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Long-term effects of prescription drugs in 174 patients treated for myocardial infarction, followed up from 4 to 5 years (the DEVENIR study)].
    Graille V; Ferrières J; Marques-Vidal P; Ruidavets JB; Rodier P; Cambou JP
    Arch Mal Coeur Vaiss; 1996 Jan; 89(1):35-9. PubMed ID: 8678736
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical impact of local implementation of agreed guidelines for the management of patients with acute myocardial infarction.
    Badano L; Cassin M; Solinas L; Burelli C; Macor F; Zanuttini D
    G Ital Cardiol; 1999 Jan; 29(1):39-47. PubMed ID: 9987046
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mortality and morbidity remain high despite captopril and/or Valsartan therapy in elderly patients with left ventricular systolic dysfunction, heart failure, or both after acute myocardial infarction: results from the Valsartan in Acute Myocardial Infarction Trial (VALIANT).
    White HD; Aylward PE; Huang Z; Dalby AJ; Weaver WD; Barvik S; Marin-Neto JA; Murin J; Nordlander RO; van Gilst WH; Zannad F; McMurray JJ; Califf RM; Pfeffer MA;
    Circulation; 2005 Nov; 112(22):3391-9. PubMed ID: 16301343
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hospital variation in use of secondary preventive medicine after discharge for first acute myocardial infarction during 1995-2004.
    Rasmussen S; Abildstrom SZ; Rasmussen JN; Gislason GH; Schramm TK; Folke F; Køber L; Torp-Pedersen C; Madsen M
    Med Care; 2008 Jan; 46(1):70-7. PubMed ID: 18162858
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug prescriptions after acute myocardial infarction: dosage, compliance, and persistence.
    Simpson E; Beck C; Richard H; Eisenberg MJ; Pilote L
    Am Heart J; 2003 Mar; 145(3):438-44. PubMed ID: 12660666
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discharge prescriptions following admission for acute myocardial infarction at tertiary care and community hospitals in Quebec.
    Beck CA; Lauzon C; Eisenberg MJ; Huynh T; Dion D; Roux R; Racine N; Carignan S; Diodati JG; Charbonneau F; Lévesque C; Pouliot J J; Pilote L L
    Can J Cardiol; 2001 Jan; 17(1):33-40. PubMed ID: 11173312
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of treatment and outcomes for patients with acute myocardial infarction in Minneapolis/St. Paul, Minnesota, and Göteborg, Sweden.
    Herlitz J; McGovern P; Dellborg M; Karlsson T; Duval S; Karlson BW; Lee S; Luepker RV
    Am Heart J; 2003 Dec; 146(6):1023-9. PubMed ID: 14660994
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differences in treatment and outcome of patients with acute myocardial infarction admitted to hospitals with compared to without departments of cardiology; results from the pooled data of the Maximal Individual Therapy in Acute Myocardial Infarction (MITRA 1+2) Registries and the Myocardial Infarction Registry (MIR).
    Gottwik M; Zahn R; Schiele R; Schneider S; Gitt AK; Fraunberger L; Bossaller C; Glunz HG; Altmann E; Rosahl W; Senges J;
    Eur Heart J; 2001 Oct; 22(19):1794-801. PubMed ID: 11549301
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relation of mortality to failure to prescribe beta blockers acutely in patients with sustained ventricular tachycardia and ventricular fibrillation following acute myocardial infarction (from the VALsartan In Acute myocardial iNfarcTion trial [VALIANT] Registry).
    Piccini JP; Hranitzky PM; Kilaru R; Rouleau JL; White HD; Aylward PE; Van de Werf F; Solomon SD; Califf RM; Velazquez EJ
    Am J Cardiol; 2008 Dec; 102(11):1427-32. PubMed ID: 19026290
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Management of acute myocardial infarction in the experience of a community hospital. A prospective study].
    Tincani E; Mazzoli V; Bondi M
    Minerva Cardioangiol; 1997; 45(7-8):335-47. PubMed ID: 9463169
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adherence to evidence-based therapies after discharge for acute coronary syndromes: an ongoing prospective, observational study.
    Eagle KA; Kline-Rogers E; Goodman SG; Gurfinkel EP; Avezum A; Flather MD; Granger CB; Erickson S; White K; Steg PG
    Am J Med; 2004 Jul; 117(2):73-81. PubMed ID: 15234641
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Drug therapy of coronary heart disease--are therapeutic guidelines being paid attention to?].
    Böger GI; Hoopmann M; Busse R; Budinger M; Welte T; Böger RH
    Z Kardiol; 2003 Jun; 92(6):466-75. PubMed ID: 12819995
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.